19 November 2017
News and Views
Links and Services
The latest issue of Inflammatory Bowel Disease evaluates impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis.
Up to 40% of patients with ulcerative colitis fail to comply with 5-aminosalicylic acid therapy.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors